메뉴 건너뛰기




Volumn 246, Issue 2, 2007, Pages 340-341

Steatosis as a risk factor in liver surgery [5]

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; IRINOTECAN; OXALIPLATIN;

EID: 34547599140     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31811ea9d2     Document Type: Letter
Times cited : (6)

References (8)
  • 2
    • 0032057111 scopus 로고    scopus 로고
    • Hepatic steatosis as a potential risk factor for major hepatic resection
    • Behrns KE, Tsiotos GG, DeSouza NF, et al. Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg. 1998;2:292-298.
    • (1998) J Gastrointest Surg , vol.2 , pp. 292-298
    • Behrns, K.E.1    Tsiotos, G.G.2    DeSouza, N.F.3
  • 3
    • 0033922244 scopus 로고    scopus 로고
    • Seven hundred forty-seven hepatectomies in the 1990s: An update to evaluate the actual risk of liver resection
    • Belghiti J, Hiramatsu K, Benoist S, et al. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg. 2000;191:38-46.
    • (2000) J Am Coll Surg , vol.191 , pp. 38-46
    • Belghiti, J.1    Hiramatsu, K.2    Benoist, S.3
  • 4
    • 10744231437 scopus 로고    scopus 로고
    • Impact of steatosis on perioperative outcome following hepatic resection
    • Kooby DA, Fong Y, Suriawinata A, et al. Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg. 2003;7:1034-1044.
    • (2003) J Gastrointest Surg , vol.7 , pp. 1034-1044
    • Kooby, D.A.1    Fong, Y.2    Suriawinata, A.3
  • 5
    • 19744365905 scopus 로고    scopus 로고
    • Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases
    • Fernandez FG, Ritter J, Goodwin JW, et al. Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J Am Coll Surg. 2005;200:845-853.
    • (2005) J Am Coll Surg , vol.200 , pp. 845-853
    • Fernandez, F.G.1    Ritter, J.2    Goodwin, J.W.3
  • 6
    • 33646457231 scopus 로고    scopus 로고
    • Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases
    • Vauthey JN, Pawlik TM, Ribero D, et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol. 2006;24:2065-2072.
    • (2006) J Clin Oncol , vol.24 , pp. 2065-2072
    • Vauthey, J.N.1    Pawlik, T.M.2    Ribero, D.3
  • 7
    • 20044374023 scopus 로고    scopus 로고
    • Design and validation of a histological scoring system for nonalcoholic fatty liver disease
    • Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313-1321.
    • (2005) Hepatology , vol.41 , pp. 1313-1321
    • Kleiner, D.E.1    Brunt, E.M.2    Van Natta, M.3
  • 8
    • 33750957147 scopus 로고    scopus 로고
    • Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases
    • Aloia T, Sebagh M, Plasse M, et al. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. J Clin Oncol. 2006;24:4983-4990.
    • (2006) J Clin Oncol , vol.24 , pp. 4983-4990
    • Aloia, T.1    Sebagh, M.2    Plasse, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.